Burning Rock Biotech (BNR) Financial Statements

90 Followers

Burning Rock Biotech Financial Overview

Burning Rock Biotech's market cap is currently $175.65M. The company's EPS TTM is $-51.8; its P/E ratio is -2.82; Burning Rock Biotech is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 539.57M	¥ 515.82M	¥ 537.43M	¥ 563.24M	¥ 507.86M
Gross Profit	¥ 402.91M	¥ 362.40M	¥ 363.23M	¥ 380.04M	¥ 364.15M
Operating Income	¥ -54.84M	¥ -357.56M	¥ -669.32M	¥ -980.41M	¥ -797.06M
EBITDA	¥ -32.00M	¥ -270.23M	¥ -517.90M	¥ -856.31M	¥ -746.50M
Net Income	¥ -55.35M	¥ -346.63M	¥ -653.69M	¥ -971.23M	¥ -796.70M
Balance Sheet
Cash & Short-Term Investments	¥ 481.39M	¥ 519.85M	¥ 615.10M	¥ 905.45M	¥ 1.50B
Total Assets	¥ 820.90M	¥ 885.30M	¥ 1.04B	¥ 1.59B	¥ 2.28B
Total Debt	¥ 43.15M	¥ 52.32M	¥ 12.32M	¥ 50.79M	¥ 86.69M
Net Debt	¥ -438.25M	¥ -467.53M	¥ -602.77M	¥ -854.66M	¥ -1.34B
Total Liabilities	¥ 285.29M	¥ 304.48M	¥ 271.59M	¥ 429.13M	¥ 433.28M
Stockholders' Equity	¥ 535.60M	¥ 580.83M	¥ 768.41M	¥ 1.16B	¥ 1.85B
Cash Flow
Free Cash Flow	¥ -33.69M	¥ -98.24M	¥ -265.17M	¥ -518.84M	¥ -691.33M
Operating Cash Flow	¥ -28.44M	¥ -92.26M	¥ -255.78M	¥ -456.81M	¥ -477.89M
Investing Cash Flow	¥ -4.39M	¥ -4.41M	¥ -9.30M	¥ -7.46M	¥ 81.70M
Financing Cash Flow	¥ 1.90M	¥ -72.00K	¥ -48.83M	¥ -86.24M	¥ -52.90M

Currency in CNY

Burning Rock Biotech Earnings and Revenue History

Income Statement >

Burning Rock Biotech Debt to Assets

Balance Sheet >

Burning Rock Biotech Cash Flow

Cash Flow >

Burning Rock Biotech Forecast EPS vs Actual EPS

Earnings >